VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 124 filers reported holding VBI VACCINES INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,996 | +79860.0% | 26,390 | +0.3% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 26,300 | 0.0% | 0.00% | – |
| Q3 2022 | $19,000 | -9.5% | 26,300 | -1.0% | 0.00% | – |
| Q2 2022 | $21,000 | -62.5% | 26,565 | -20.9% | 0.00% | – |
| Q1 2022 | $56,000 | -29.1% | 33,565 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $79,000 | -21.8% | 33,565 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $101,000 | -11.4% | 32,565 | -4.4% | 0.00% | 0.0% |
| Q2 2021 | $114,000 | -8.1% | 34,065 | -14.5% | 0.00% | 0.0% |
| Q1 2021 | $124,000 | +21.6% | 39,850 | -15.4% | 0.00% | 0.0% |
| Q4 2020 | $102,000 | +2.0% | 47,100 | +34.8% | 0.00% | 0.0% |
| Q3 2020 | $100,000 | +51.5% | 34,950 | +64.9% | 0.00% | 0.0% |
| Q2 2020 | $66,000 | +1220.0% | 21,200 | +92.7% | 0.00% | – |
| Q3 2019 | $5,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |